Co-author: Daniel Beachler
https://orcid.org/0000-0003-2788-3061
Co-authored publications (7):
- Hoffman P , Parlett LE , Beachler DC et al . Validation of claims-based algorithms for newly diagnosed juvenile idiopathic arthritis using machine learning methods . Poster presented at: 2023 American College of Rheumatology (ACR) Convergence; November 10 - November 15, 2023; San Diego, CA, US . https://acr23.eventscribe.net/searchGlobal.asp?mode=Presentations&SearchQuery=0353 .
- Cook M , Beachler DC , Parlett LE , Cochetti PT , Finkle WD , Lanes S . Abstract 5050: testosterone supplementation in relation to prostate cancer in a us commercial insurance claims database . Poster presented at: 2019 American Association for Cancer Research (AACR) Annual Meeting; March 29 - April 03, 2019; Atlanta, GA, US . https://aacrjournals.org/cancerres/article/79/13_Supplement/5050/636990/Abstract-5050-Testosterone-supplementation-in . doi: 10.1158/1538-7445.AM2019-5050 .
- Anthony MS , Djebarri L , Beachler DC et al . Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 ras) . Poster presented at: 2023 American Diabetes Association Scientific Sessions; June 23 - June 26, 2023; San Diego, CA, US . https://diabetesjournals.org/diabetes/article/72/Supplement_1/846-P/150217/846-P-Risk-of-Anaphylaxis-among-New-Users-of . doi: 10.2337/db23-846-P .
- Anthony MS , Aroda VR , Parlett LE et al . Risk of anaphylaxis among new users of GLP-1 receptor agonists: a cohort study .Diabetes Care. 2024; 47 (4) : 712-9 . doi: 10.2337/dc23-1911 .
- Cook M , Beachler DC , Parlett LE et al . Testosterone therapy in relation to prostate cancer in a U.S. commercial insurance claims database .Cancer Epidemiol Biomarkers Prev. 2020; 29 (1) : 236-45 . doi: 10.1158/1055-9965.EPI-19-0619 .
- Parlett LE , Beachler DC , Lanes S , Hoover R , Cook M . Validation of an algorithm for claims-based incidence of prostate cancer .Epidemiology. 2019; 30 (3) : 466-71 . doi: 10.1097/EDE.0000000000001007 .
- Beachler DC , Parlett LE , Lanes S , Hoover R , Cook M . Testosterone supplementation in relation to prostate cancer in a us commercially-insured claims database . Podium presented at: 2018 International Society for Pharmacoepidemiology International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22 - August 26, 2018; Praha 4-Nusle, CZ .